Second-order advantage applied to simultaneous spectrofluorimetric determination of paracetamol and mefenamic acid in urine samples

Development of an eco-friendly fluorescent probe for mefenamic acid sensing in pharmaceuticals and biofluids

Mefenamic acid, renowned for its analgesic properties, stands as a reliable choice for alleviating mild to moderate pain. However, its versatility extends beyond pain relief, with ongoing research unveiling its promising therapeutic potential across diverse domains. A straightforward, environmentally friendly, and sensitive spectrofluorometric technique has been developed for the precise quantification of the analgesic medication, mefenamic acid. This method relies on the immediate reduction of fluorescence emitted by a probe upon interaction with varying concentrations of the drug. The fluorescent probe utilized, N-phenyl-1-naphthylamine (NPNA), was synthesized in a single step, and the fluorescence intensities were measured at 480 nm using synchronous fluorescence spectroscopy with a wavelength difference of 200 nm. Temperature variations and lifetime studies indicated that the quenching process was static. The calibration curve exhibited linearity within the concentration range of 0.50-9.00 μg/mL, with a detection limit of 60.00 ng/mL. Various experimental parameters affecting the quenching process were meticulously examined and optimized. The proposed technique was successfully applied to determine mefenamic acid in pharmaceutical formulations, plasma, and urine, yielding excellent recoveries ranging from 98% to 100.5%. The greenness of the developed method was evaluated using three metrics: the Analytical Eco-scale, AGREE, and the Green Analytical Procedure Index.

Application of Gd2ZnMnO6/ZnO nanocomposite for electrochemical measurement of acetaminophen, diphenhydramine, and phenylephrine

An electrochemical sensor with high sensitivity was designed and used to measure several drugs, including acetaminophen (AC), diphenhydramine (DPH), and phenylephrine (PHE). This sensor was created using a carbon paste electrode (CPE) that has been modified with a Gd2ZnMnO6/ZnO nanocomposite. In order to analyze the developed sensor, scanning electron microscopy with energy dispersive X-ray spectroscopy (SEM), X-ray diffraction (XRD), and Fourier-transform infrared spectroscopy (FT-IR) techniques were used. The electrochemical behavior of the modified electrode was investigated by cyclic voltammetry, chronoamperometry, and apparent resistance spectroscopy methods. Also, the compound's diffusion coefficient (D) was calculated. By using the differential pulse voltammetry, AC, DPH, and PA were determined with detection limits of 2.5 × 10-8, 3.3 × 10-8, and 1.4 × 10-8 M in the linear concentration ranges of 0.09-900 μM. Finally, the designed sensor was utilized to measure the drug in real samples, and acceptable results were obtained.

Biomass-Derived Core-Shell Carbon Dots with Embedded Tripodal Receptors for the Selective Recognition of Mefenamic Acid in Pharmaceutical Formulations and Urine

A tripodal amine (TPA) with -OH, N, and S donors is synthesized to functionalize a core-shell carbon dot composite (FCDs@SiO2-TPA) for sensing application. The TPA is characterized by spectroscopic and spectrometric techniques, and the composite is characterized by Fourier transform infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), Brunauer-Emmett-Teller (BET), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and energy-dispersive X-ray spectra (EDS) techniques. The composite has the ability to recognize mefenamic acid (MFA) selectively even in the presence of other drugs like ibuprofen sodium, acetylsalicylic acid, naproxen sodium, diclofenac sodium, and ketoprofen. It can also be used for the quantification of MFA by recording the emission quenching response of the sample at λexc. = 350 nm and λems. = 460 nm (linear range = 1-8 μM and LOD = 197 nM). The density functional theory calculations and 1H NMR titration suggest quenching of the emission signal due to photoinduced electron transfer via hydrogen bonding between the probe and MFA. The composite FCDs@SiO2-TPA has been demonstrated as a reliable and cost-effective sensing probe for the detection of MFA in pharmaceutical formulations, water samples, and cow urine samples.

An Efficient Electrochemical Sensor Based on NiCo2O4 Nanoplates and Ionic Liquid for Determination of Favipiravir in the Presence of Acetaminophen

Based on the modification of carbon paste electrode with NiCo2O4 nanoplates and 1-hexyl-3-methylimidazolium tetrafluoroborate, a new electrochemical sensing platform for the sensing of favipiravir (a drug with potential therapeutic efficacy in treating COVID-19 patients) in the presence of acetaminophen was prepared. For determining the electrochemical behavior of favipiravir, cyclic voltammetry, differential pulse voltammetry, and chronoamperometry have been utilized. When compared to the unmodified carbon paste electrode, the results of the cyclic voltammetry showed that the proposed NiCo2O4 nanoplates/1-hexyl-3-methylimidazolium tetrafluoroborate/carbon paste electrode had excellent catalytic activity for the oxidation of the favipiravir in phosphate buffer solution (pH = 7.0). This was due to the synergistic influence of 1-hexyl-3-methylimidazolium tetrafluoroborate (ionic liquid) and NiCo2O4 nanoplates. In the optimized conditions of favipiravir measurement, NiCo2O4 nanoplates/1-hexyl-3-methylimidazolium tetrafluoroborate/carbon paste electrode had several benefits, such as a wide dynamic linear between 0.004 and 115.0 µM, a high sensitivity of 0.1672 µA/µM, and a small limit of detection of 1.0 nM. Furthermore, the NiCo2O4 nanoplates/1-hexyl-3-methylimidazolium tetrafluoroborate/carbon paste electrode sensor presented a good capability to investigate the favipiravir and acetaminophen levels in real samples with satisfactory recoveries.

Novel Deconvoluted Synchronous Spectrofluorimetric Method For Simultaneous Determination Of Bisoprolol and Atorvastatin As Single or Co-administrated Drugs in Bulk and Plasma; Green Assessment

Atorvastatin and bisoprolol are two medications often prescribed together for the management of cardiovascular disease and to reduce mortality. Through a simple and direct technique based on deconvolution and synchronous of the spectrofluorometric spectra, the innovative method enables simultaneous quantification of bisoprolol and atorvastatin as single or co-formulated dosage forms in bulk and plasma. The method depends on measuring the amplitudes of bisoprolol and atorvastatin at 298 nm and 363 nm directly after deconvolution where the other drug doesn't show interference. The linearity of the method was 0.02-0.5 µg/mL and 0.3-25 µg/mL for bisoprolol and atorvastatin, respectively. LOD and LOQ were 0.004, 0.085 µg/mL and 0.013, 0.259 µg/mL for bisoprolol and atorvastatin respectively. Furthermore, green assessment of the method using Eco-Scale and GAPI scale. The method was precise, economical, simple, smart, time-saving and eco-friendly, which allowed its application in quality control unit and in lab assessment.

A novel temperature-responsive electrochemical sensing platform for reversible switch-sensitive detection of acetamidophenol

A novel facile, quick, and temperature-controlled sensor was constructed based on a polystyrene-poly-N,N-diethyl acrylamide-polystyrene (PS-PDEAM)/carboxylated multi-walled carbon nanotube (MWCNT) composite modified glass carbon electrode. The sensor achieves acetaminophen (AP) reversibility through better temperature sensitivity. PS-PDEAM shrinks when the temperature exceeds its lower critical temperature (LCST). When AP molecules pass through the modified interface, the electron transfer rate is accelerated, and the sensor is turned on. In the off state, the electrochemical response of AP cannot be detected. Under ideal experimental conditions, for composite modified films, there is a wide detection range of AP between 1.5-85.1 μM and 85.1-235.1 μM, and the limit of detection of acetaminophen is as low as 0.57 μM (S/N = 3). This method has been successfully applied to the determination of AP in tablets, and shows high stability, good reproducibility and excellent anti-interference ability. The on-off sensor opens up a wide range of possibilities for the use of temperature-sensitive polymers in electro-catalysis, sensors, and environmental pollutant monitoring.

Au-PEDOT/rGO nanocomposites functionalized graphene electrochemical transistor for ultra-sensitive detection of acetaminophen in human urine

A novel graphene electrochemical transistor (GECT) sensor based on Au-poly(3,4-ethylenedioxythiophene)/reduced graphene oxide (Au-PEDOT/rGO) nanocomposites functionalized the gate electrode and monolayer graphene as channel was proposed and constructed for the ultra-sensitive detection of acetaminophen (AP). Au-PEDOT/rGO nanocomposites were synthesized by a simple one-pot method to modify the gate electrode of GECT. With the high catalytic activity of Au nanoparticles, the good conductivity and stability of PEDOT, the large specific surface area and abundant adhesion sites of rGO, the sensitivity and stability of the device for AP detection could be effectively improved. The sensing mechanism of the device was that the electrochemical reactions of the AP on the surface of gate electrode causes the effective gate voltage on the GECT to change, thereby adjusting the carrier concentration and current of the graphene channel. Combined with the excellent catalytic properties of Au-PEDOT/rGO nanocomposites and the high carrier mobility of the graphene channel, the resulting device has remarkable sensing performance for AP, with a detection limit as low as 1 nM and a linear range from 1 nM to 8 mM. In addition, the device has good anti-interference ability and accuracy in the detection of AP in urine samples and tablets, which proved that it could be used to determine AP in human non-invasive and pharmaceutical products. The GECT sensor based on Au-PEDOT/rGO provides an efficient, sensitive and cost-effective sensing platform for AP detection, and is expected to realize in vitro diagnosis of diseases.

A novel electrochemical sensor based on TAPT-TFP-COF/COOH-MWCNT for simultaneous detection of dopamine and paracetamol

In this work, a covalent organic framework (COF) TAPT-TFP-COF containing a triazine ring was prepared by a typical Schiff base condensation reaction of 1,3,5-tris-(4-aminophenyl)triazine (TAPT) and 1,3,5-triformyl phloroglucinol (TFP). The TAPT-TFP-COF and carboxyl-functionalized multi-wall carbon nanotubes (COOH-MWCNTs) were drip-coated on glassy carbon electrode respectively to develop a novel and simple electrochemical sensor in order to simultaneously detect dopamine (DA) and paracetamol (PA). COOH-MWCNTs interconnected the TAPT-TFP-COF and acted as bridges between the COF particles, which had a good synergistic effect and accelerated electron transfer. Under optimal conditions, linear responses were obtained over the concentration range 1-190 μM for DA and PA with limits of detection (LOD) of 0.14 μM and 0.19 μM, respectively. Furthermore, the fabricated sensor possesses outstanding repeatability and high selectivity, and can be applied for the determination of DA and PA in dopamine injection and acetaminophen drugs with satisfactory recoveries.

Electrochemical sensors based on carbon nanomaterials for acetaminophen detection: A review

This study describes the advancements made over the last five years in the development of electrochemical sensors and biosensors for acetaminophen detection. This study reviews the different configurations based on unmodified and chemically modified carbon nanotubes and graphene. The influence of various modifiers on the two types of materials is presented along with their role on the enhancement of the selectivity and sensitivity of (bio)sensors. The review is focused on a comparative description of the applications of carbon-based nanomaterials towards acetaminophen detection and presents the results in a critical manner.

Magnetic solid phase extraction of mefenamic acid from biological samples based on the formation of mixed hemimicelle aggregates on Fe(3)O(4) nanoparticles prior to its HPLC-UV detection

A novel and sensitive solid phase extraction method based on the adsorption of cetyltrimethylammonium bromide on the surface of Fe3O4 nanoparticles was developed for extraction and preconcentration of ultra-trace amounts of mefenamic acid in biological fluids. The remarkable properties of Fe3O4 nanoparticles including high surface area and strong magnetization were utilized in this SPE procedure so that a high enrichment factor (98) and satisfactory extraction recoveries (92-99%) were obtained using only 50mg of magnetic adsorbent. Furthermore, a fast separation time (about 15min) was achieved for a large sample volume (200mL) avoiding time-consuming column-passing process of conventional SPE. A comprehensive study on the parameters effecting the extraction recovery such of the amount of surfactant, pH value, the amount of Fe3O4 nanoparticles, sample volume, desorption conditions and ionic strength were also presented. Under the optimum conditions, the method was linear in the 0.2-200ngmL(-1) range and good linearity (r(2)>0.9991) was obtained for all calibration curves. The limit of detection was 0.097 and 0.087ngmL(-1) in plasma and urine samples, respectively. The relative standard deviation (RSD %) for 10 and 50ngmL(-1) of the analyte (n=5) were 1.6% and 2.1% in plasma and 1.2% and 1.9% in urine samples, respectively. Finally, the method was successfully applied to the extraction and preconcentration of mefenamic acid in human plasma and urine samples.